CC
ATYR icon

Checkpoint Capital’s aTyr Pharma ATYR Stock Holding History

Checkpoint Capital’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,814
Closed -$1.57M – 21
2024
Q4 		$1.57M Sell
10,814
-32,598
-75% -$3.95M 0.8% 15
2024
Q3 		$3.06M Sell
43,412
-5,250
-11% -$382K 1.52% 10
2024
Q2 		$3.04M Buy
48,662
+12,500
+35% +$870K 1.83% 9
2024
Q1 		$2.82M Sell
36,162
-1,427
-4% -$100K 1.89% 11
2023
Q4 		$2.12M Buy
+37,589
New +$1.93M 1.28% 13

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Checkpoint Capital's ATYR Position: Q1 2025 in Review

Checkpoint Capital sold out of aTyr Pharma (ATYR) in Q1 2025, closing a stake of 10,814 shares — an estimated $1.57M sold.

Checkpoint Capital first reported a position in ATYR in Q4 2023 and held it in 5 quarters. The position peaked at $3.06M in Q3 2024. 85 funds tracked by Wall St. Rank hold ATYR as of Q1 2025.

  • Checkpoint Capital reported no remaining aTyr Pharma position as of Q1 2025 after selling out during the quarter.
  • Checkpoint Capital sold 10,814 aTyr Pharma shares in Q1 2025, an estimated $1.57M.
  • Checkpoint Capital first reported a position in aTyr Pharma in Q4 2023 and held it in 5 quarters.
  • Checkpoint Capital's aTyr Pharma position peaked at $3.06M in Q3 2024.
  • 85 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2025.

Based on Checkpoint Capital's 13F filing for Q1 2025, filed 15 May 2025.